Skip to main content

Claire Exaus, Rph, PharmD

Specialty in Clinical Informatics

Claire J. Exaus, RPh, PharmD, is a clinical informatics pharmacist and digital health strategist and an IT Project Management intern at Rapid7. Dr. Exaus previously led the Internal Medicine pharmacy services at Beth Israel Deaconess Medical Center, Boston, MA for five years where she served as a Population Health Analyst and Ambulatory Care Pharmacist. She has been in the field of consulting on Regulatory and Compliance for over 10 years. Her expertise includes risk evaluations and mitigation strategies. Dr. Exaus’ background spans ambulatory care, inpatient pharmacy, oncology, research and retail.

A lifelong learner uniquely attuned to the intersection of technology and medicine, Dr. Exaus is dedicated to improving patient care by amplifying access, multidisciplinary collaboration, connection, and innovation through data. She has created pharmacy programs, led successful software implementations, informed key policy development, and made countless contributions to improved outcomes via increased patient and provider engagement. Passionate about impacting patients’ quality of life domestically and abroad, Dr. Exaus has completed numerous short-term medical mission trips to Haiti. Most recently, Dr. Exaus has collaborated with FEMA and Black Boston Coalition in the COVID-19 vaccination effort traveling locally and to other states.

Education and training

2020-2022 - Masters in Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy & Allied Health Sciences, Boston, MA

2012-2014 - Masters in Healthcare Informatics, University of Cincinnati, Cincinnati, OH

2007-2010 - Doctorate in Pharmacy, Nova Southeastern University, Davie, FL

1995-1997 - Bachelor of Science in Pharmacy, Massachusetts College of Pharmacy & Allied Health Sciences, Boston, MA

Certifications

American Pharmacist Association Immunization Certified

Publication Highlights

Why Should Health Care Workers Be Vaccinated Against The Flu?

Consumers' Knowledge of OTC GENERICS: A PHARMACIST INTERVENTION STUDY